Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Anticancer Research|May 30, 2012
β-Galactosidase treatment is a common first-stage modification of the three major subtypes of Gc protein to GcMAFYoshihiro Uto, Syota Yamamoto, Hirotaka Mukai, et al.
Cancer Letters|March 9, 2007
Suppression of tumor-induced angiogenesis by Brazilian propolis: major component artepillin C inhibits in vitro tube formation and endothelial cell proliferationMok-Ryeon Ahn, Kazuhiro Kunimasa, Toshiro Ohta, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|June 7, 2006
The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapyShin-Ichiro Masunaga, Hideko Nagasawa, Yoshinori Sakurai, et al.
Anticancer Research|November 24, 2005
Innate-immune therapy for lung carcinoma based on tissue-macrophage activation with lipopolysaccharideMami Hino, Chie Kohchi, Takashi Nishizawa, et al.
Bioscience, Biotechnology, and Biochemistry|July 13, 2012
Characterization of coumarin-specific prenyltransferase activities in Citrus limon peelRyosuke Munakata, Tsuyoshi Inoue, Takao Koeduka, et al.
Bioorganic & Medicinal Chemistry|January 30, 2002
Synthesis and biological activities of fluorinated chalcone derivativesChika Nakamura, Nobuhide Kawasaki, Hideki Miyataka, et al.
Advances in Experimental Medicine and Biology|March 6, 2010
Design of novel hypoxia-targeting IDO hybrid inhibitors conjugated with an unsubstituted L-TRP as an IDO affinity moietyHitomi Nakashima, Kazuhiro Ikkyu, Kouichiro Nakashima, et al.
Anticancer Research|July 31, 2014
Case report: A breast cancer patient treated with GcMAF, sonodynamic therapy and hormone therapyToshio Inui, Kaori Makita, Hirona Miura, et al.
Oncology Reports|July 14, 2005
Combination of the antivascular agent ZD6126 with hypoxic cytotoxin treatment, with reference to the effect on quiescent tumor cells and the dependency on p53 status of tumor cellsShin-Ichiro Masunaga, Hideko Nagasawa, Yoshihiro Uto, et al.
Bioorganic & Medicinal Chemistry|November 22, 2007
Design, synthesis, and radiosensitizing activities of sugar-hybrid hypoxic cell radiosensitizersTakashi Nakae, Yoshihiro Uto, Motoko Tanaka, et al.
Pageof 11